Clorox Company reported that its Chief Executive Officer and director had 829 shares of common stock withheld on December 12, 2025 at a price of $102.83 per share. According to the explanation, the company withheld these shares to satisfy employment tax obligations applicable to restricted stock units previously granted to retirement eligible employees. After this tax-related share withholding, the executive directly beneficially owns 201,161 shares of Clorox common stock.
Clorox Company executive reports a small share withholding for taxes. A vice president who serves as CAO and corporate controller reported that on 12/12/2025 the company withheld 24 shares of common stock at $102.83 per share. This withholding was used to satisfy employment tax obligations tied to previously granted restricted stock units for retirement-eligible employees.
After this transaction, the officer beneficially owns 6,968 Clorox shares directly and 100 shares indirectly through a trust of a parent, indicating the filing reflects routine tax-related share withholding rather than an open-market sale.
Clorox Company reported that its EVP - Chief Admin Officer had 310 shares of common stock withheld on 12/12/2025 to cover employment tax obligations tied to previously granted restricted stock units. The shares were valued at $102.83 each for this tax-related withholding. Following this routine transaction, the officer directly beneficially owns 37,970 shares of Clorox common stock.
The Clorox Company executive reported a routine tax-related share withholding. On 12/12/2025, the EVP–Group President, Health & Hygiene had 133 shares of Clorox common stock disposed of at $102.83 per share in a transaction coded "F," which denotes shares applied to obligations such as taxes. According to the explanation, the Company withheld these shares to satisfy employment tax obligations tied to restricted stock units previously granted to "retirement eligible employees." After this transaction, the executive directly beneficially owned 35,000 shares of Clorox common stock.
Clorox Co. reported a small insider share disposition by an executive officer who serves as EVP - Executive Chief of Staff. On 12/12/2025, 65 shares of Clorox common stock were disposed of at $102.83 per share in a transaction coded “F,” reflecting shares withheld by the company to cover employment tax obligations on previously granted restricted stock units to a retirement-eligible employee.
After this tax-related withholding, the executive beneficially owns 32,138 shares of Clorox common stock in direct ownership.
Clorox Co. reported an insider share transaction by its EVP - Chief Legal Officer. On 12/12/2025, 347 shares of common stock were withheld at $102.83 per share. This was described as a company withholding of shares to satisfy employment tax obligations on previously granted restricted stock units for a retirement-eligible employee.
After this tax-related transaction, the executive beneficially owns 29,787 shares of Clorox common stock directly and 619.721 shares indirectly through a 401(k) plan. The filing is an ownership update rather than an open-market purchase or sale.
Clorox Co. (CLX) reported an insider equity transaction by a director. On 11/21/2025, a trust associated with the director acquired 4,000 shares of Clorox common stock at a weighted average price of $104.1291 per share, as shown in Table I.
Following this transaction, the trust beneficially owned 13,000 Clorox shares, reported as indirect ownership. The filing notes that the 4,000-share trade was executed in multiple transactions at prices ranging from $104.00 to $104.24, with the single price reported reflecting the weighted average of those trades.
The Clorox Company reported results of its virtual annual shareholder meeting held on November 19, 2025. Shareholders elected all company nominees to the board of directors, confirming the full slate of directors listed in the meeting materials.
Investors also approved, on an advisory basis, the compensation of Clorox’s named executive officers, indicating support for the company’s executive pay program. In addition, shareholders ratified the selection of Ernst & Young LLP as Clorox’s independent registered public accounting firm for the fiscal year ending June 30, 2026, allowing the firm to continue in its audit role.
The Clorox Company (CLX) reported Q1 FY26 results with lower sales and earnings. Net sales were $1,429 million, down 19% year over year, as shipments normalized after ERP-related pull-forward in Q4 FY25. Gross profit was $596 million and gross margin declined to 41.7% from 45.8%, reflecting lower volume and higher manufacturing and logistics costs, partly offset by savings. Diluted EPS was $0.65 versus $0.80.
Operating cash flow was $93 million (vs. $221 million), driven by lower cash earnings and inventory, offset by lower receivables and higher payables. Current liabilities exceeded current assets by $539 million, primarily due to the upcoming cash purchase of P&G’s 20% Glad venture interest; the estimated fair value of that interest was $476 million, with $488 million recognized in accounts payable and accrued liabilities. Clorox cites expected operating cash flow, strong credit ratings, and available borrowing capacity to fund needs; its $1,200 million revolver was undrawn.
By segment, net sales declined: Health & Wellness $565 million (-19%), Household $362 million (-19%), Lifestyle $245 million (-23%), and International $253 million (-2%). The effective tax rate was 23.4% (vs. 41.8%). Dividends declared were $2.48 per share; share repurchases totaled $129 million.
The Clorox Company filed a Form 8-K to share its latest quarterly performance information. The company reported that it issued a press release detailing its financial results for the first quarter ended September 30, 2025, and made this document available as Exhibit 99.1.
The filing also includes supplemental financial information as Exhibit 99.2, offering additional detail on the quarter’s results. Together, these materials provide investors and analysts with a fuller picture of Clorox’s recent operating performance and financial condition.